NCT05812209

Stellate Ganglion Block to Treat Long COVID 19 Case Series

Stellate Ganglion Block to Treat Long COVID-19 Syndrome, A 41 Patient Retrospective Cohort Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 41 (actual)
• Sponsor: Metamorphosis LTD · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

An assessment of the effectiveness of Stellate Ganglion Block in alleviating symptoms of Long COVID-19.

Detailed description

We evaluated the treatment results of 41 patients (18 male and 23 female) aged between 18 and 89, who received Stellate Ganglion Block (SGB) with Ultrasound guidance for Long COVID-19 Syndrome. The patients were from the United States and received treatment at our Colorado clinics during the period of September to December 2022.Those who responded to our post-procedure follow-up calls were included in the study population.

Conditions

• Long COVID
• Long Covid19
• Post-COVID-19 Syndrome
• Post Acute COVID-19 Syndrome
• Dysautonomia
• Anosmia
• Dysgeusia
• Brain Fog
• Muscle Pain
• Shortness of Breath
• Dizziness
• Fatigue Post Viral
• Cough
• Menstrual Cycle Abnormal
• Pain

Interventions

Type	Name	Description
PROCEDURE	Stellate Ganglion Block	Ultrasound guided block of the Stellate Ganglion with local anesthetics.

Timeline

• Start date: 2022-09-01
• Primary completion: 2022-12-31
• Completion: 2022-12-31
• First posted: 2023-04-13
• Last updated: 2023-04-13

Locations

1 site across 1 country: United States